[Review of histamine H2 receptor antagonists].
D000818:Animals; D000897:Anti-Ulcer Agents / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D002490:Central Nervous System / Q000187:drug effects; D002927:Cimetidine / Q000494:pharmacology; D004347:Drug Interactions; D004700:Endocrine System Diseases / Q000139:chemically induced; D004943:Esophagogastric Junction / Q000187:drug effects; D005755:Gastrins / Q000378:metabolism; D006635:Histamine H2 Antagonists / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects; D010437:Peptic Ulcer / Q000188:drug therapy; D011899:Ranitidine / Q000494:pharmacology; D051381:Rats; D011970:Receptors, Histamine H2 / Q000187:drug effects
D000897:Anti-Ulcer Agents; D005755:Gastrins; D006635:Histamine H2 Antagonists; D011970:Receptors, Histamine H2; D002927:Cimetidine; D011899:Ranitidine
Revisión de los antagonistas de los receptores H2 de la histamina.